Clinical utility of personalized reference intervals for CEA in the early detection of oncologic disease
PrRI approaches could be an effective tool to rule out new oncological findings during the active surveillance of patients.
Authors
- Jorge Díaz–Garzón (ORCID: https://orcid.org/0000-0002-3171-1505)
- Pilar Fernández–Calle (ORCID: https://orcid.org/0000-0002-7823-593X)
- Álvaro González (ORCID: https://orcid.org/0000-0002-1423-273X)
- Nerea Varo (ORCID: https://orcid.org/0000-0002-2362-9472)
- Estíbaliz Alegre (ORCID: https://orcid.org/0000-0002-9053-3606)
- Patricia Fuentes-Bullejos (ORCID: https://orcid.org/0000-0001-8465-2564)
- D. Martínez (ORCID: https://orcid.org/0000-0002-5344-8402)
- Hugo Casero-Ramírez
Institutions
- Hospital Universitario La Paz (ES)
- Navarre Institute of Health Research (ES)
- Clinica Universidad de Navarra (ES)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2024-08-05
- DOI
- https://doi.org/10.1515/cclm-2024-0546
- Citations
- 6
- Primary Topic
- Clinical Laboratory Practices and Quality Control
- Type
- article
- Field-Weighted Citation Impact
- 1.96